New 1,2,4-triazoles (1) having a difluoro(heteroaryl)methyl moiety were designed and synthesized via 1-aryl-2,2-difluoro-2-(heteroaryl)ethanones (2), which were prepared by two routes starting from the reaction of ethyl 2,2-difluoro(heteroaryl)acetate with phenyllithiums (Route A) and from the reaction of chlorodifluoro(heteroaryl)methane with benzaldehydes (Route B). The compounds 1 except for 1g show antifungal activities against yeasts and filamentous fungi in vitro, especially (؉)-1f have equal or superior activities compared to those of itraconazole.
The treatment of systemic mycoses have been a problem in the immunocompromised patient, and partly be due to the improved recognition and diagnosis of fungal infections. Another contributory factor are the prolonged survival of patients with global defects in their host defense mechanisms including patients with neoplastic diseases, organ transplant, diabetics and AIDS.
1,2,4-Triazole antifungals inhibit the biosynthesis of the cell membrane in fungi by direct interaction with cytochrome P-450 which acts on the 14-a-demethylation of lanosterol. 1) For the treatment of systemic mycoses such as candidosis and cryptococcosis in immunocompromised patients, 1,2,4-triazole antifungals such as fluconazole (FLCZ) and itraconazole (ITCZ) have been used.
2) However, FLCZ is not effective against aspergillosis, and ITCZ is not so efficacy in vivo because of its poor solubility and low bioavailability. And recently, the resistance to FLCZ in Candida albicans (C. albicans) has been reported.
3) Therefore more effective and safer drugs with broader spectra have been desired and many 1,2,4-triazole antifungals containing the heterocyclic moiety were developed, such as voriconazole, 4) SCH-56592, 5) ER-30346, 6 ) D-0870, 7) UR-9825, 8) and TAK-187. 9) It is well known that the introduction of a fluorine atom into an organic molecule causes dramatic changes in its biological activities, 10) mainly due to the high electronegativity of fluorine, the strong carbon-fluorine bond, and increased solubility in lipids. Therefore, we designed the 1,2,4-triazole derivatives (1) with difluoro(heteroaryl)methyl moiety as shown in Chart 1. In this paper, we will describe the synthesis of 1 and their antifungal activities.
Chemistry The designed compounds 1 can be prepared from key intermediates, aryl difluoro(heteroaryl)methyl ketones (2) , by the usual methods, which are prepared via Routes A and B. Route A consists of two reactions, namely the coupling reaction of heteroaryl halides with a copper-difluoroacetate complex, followed by the reaction of the cou-pling products, 2,2-difluoro(heteroaryl)acetates, with aryllithiums. Also Route B consists of two reactions, namely the reaction of benzaldehydes with Reformatsky reagents prepared from chlorodifluoro(heteroaryl)methanes followed by the oxidation reaction of the resulting alcohols.
The coupling reaction of the copper-difluoroacetate complex with heteroaryl halides has been reported by Kobayashi et al. 11) and recently by Kumadaki et al. 12) Kobayashi reported the coupling reaction of aliphatic, aromatic, and heteroaromatic halides with ethyl iododifluoroacetate, and Kumadaki reported the coupling reaction of aliphatic and aromatic iodides with commercially available ethyl bromodifluoroacetate. Therefore, we carried out the coupling reaction of various heteroaryl halides with the copper-difluoroacetate complex prepared from copper powder and commercially available ethyl bromodifluoroacetate.
The results are summarized in Table 1 . According to the Table 1 , dimethyl sulfoxide (DMSO) (Run 12) is more preferred than N,N-dimethylformamide (DMF) (Run 11) and hexamethylphosphoramide (HMPA) (Run 13) as the solvent. The reactions using ethyl bromodifluoroacetate proceeded at room temperature, while the reaction using ethyl chlorodifluoroacetate did not proceed at 55°C in DMSO (Run 2). The results in Table 1 show that most heteroaryl iodides produced products (4) in moderate to good yields while the bromides showed moderate yields. When the reactions did not proceed, the reaction slightly proceeded by the addition of copper(I) iodide (Run 10).
Prepared compounds (4a-k) were then allowed to react with 4-and 2,4-substituted phenyllithiums, which were derived from the corresponding bromides by the reaction with n-butyllithium in tetrahydrofuran (THF) at Ϫ78°C, to give 1-aryl-2,2-difluoro-2-heteroarylethanones (2a-l).
In the reaction of ethyl 2-(5-bromo-2-pyridyl)-2,2-difluoroacetate (4b) with 2,4-difluorophenyllithium prepared from 2,4-difluorobromobenzene, the yield of 2-(5-bromo-2-pyridyl)-2,2-difluoro-1-(2,4-difluorophenyl)ethanone (2b) was low owing to the formation of 2,6-difluorophenyllithium by autometallation of the aryllithium.
13) Namely, 2-(5-bromo-2-pyridyl)-2,2-difluoro-1-(2,6-difluorophenyl)-1-ethanone (2b) was obtained as the major product (2b : 2bϭ6 : 11) when THF was used as the solvent. However, the reaction in diethyl ether gave 2b as the sole product in good yield without contamination of 2b.
Other 1-aryl-2,2-difluoro-2-heteroarenes (2m-p) were prepared by the oxidation of the corresponding alcohols (6m-p), which were synthesized from 2-(chlorodifluoromethyl)benzo-1,3-azoles (5) 14) and arylaldehydes using the Reformatsky-type reaction.
Namely, Reformatsky-type reagents prepared from commercially available 2-(chlorodifluoromethyl)benzo-1,3-azoles (5) and zinc in DMF were allowed to react with 4-or 2,4-substituted benzaldehydes at 70°C to give the 1-aryl-2,2-difluoro-2-heteroarylethanols (6m-p). Oxidation of the alcohols (6m-p) with activated manganese(IV) oxide in chloroform at room temperature for 15 h gave the corresponding ketones (2m-p). Other strong oxidants such as potassium permanganate, potassium dichromate, and pyridinium chlorochromate caused C-CF 2 bond cleavage of 6 to generate the corresponding benzaldehydes or benzoic acids without the formation of 2.
Compounds 2a-p were allowed to react with trimethylsulfoxonium iodide (TMSI) in the presence of sodium hydride in DMSO to give compounds 7a-p. In the cases producing products (7) in low yields, the reaction of 2 with diazomethane is an alternative method, e.g., the yields of 7e and 7n were significantly improved from 9% to 81.8% and from 22.8% to 85%, respectively.
Finally, compounds 7a-p were allowed to react with 1,2, 4-triazole in the presence of potassium carbonate in DMF to give the expected compounds (1a-p). 1b, 1c, 1f and 1o, which show strong antifungal activities, were optically resolved to (ϩ)-1 and (Ϫ)-1 by chiral separation column chromatography.
For comparison, unfluorinated pyridylmethylene derivative (8) 15) was prepared from 2-methylpyridine and 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole-1-yl)ethanone. Table 2 .
Many of these compounds showed excellent in vitro antifungal activities. Their activities were generally and exceptionally high against C. albicans and T. rubrum and were good against the others. The introduction of fluorine atoms enhanced in vitro antifungal activities A. fumigatus, A. flavus, T. mentagrophytes and T. mentagrophyte (1a and 8).
As phenyl substituents, the 2,4-difluoro derivative (1f) and 4-fluoro derivative (1k) were superior over the 4-trifuoromethyl derivative (1l). As a heteroaromatic moiety, pyridine (1a, b), quinoline (1c), thiophene (1f), thiazole (1j), and the benzothiazole derivatives (1o) showed higher activities than pyrimidine (1d), furan (1e), pyrazole (1h), isoxazole (1i), benzimidazole (1m), and the benzoxazole derivatives (1n). On the other hand, the indole derivative (1g) did not show any antifungal activities. The conformation of 1e, 1g, voriconazole and lanosterol were calculated by PM3. 17) We used R configuration in PM3 calculation, because R configuration of 1e is well overlapped with voriconazole, whose absolute configuration is determined. The superimposition of 1e and voriconazole (a), and that of 1e and lanosterol (b) are shown in Fig. 2 . We presume that the compounds 1 except for 1g interact with cytochrome P-450 with this form and show antifungal activities.
In the lowest energy conformer of 1e, the distance of fluorine atom of difluoromethylene group and oxygen atom of hydroxy group is 2.88 Å that suggests the existence of hydrogen bond. We presume that the hydrogen bond of these atoms contributes to the stabilization of the configuration. Similar contribution of hydrogen bond were observed in compound (6) . For example, in the 1 H-NMR spectrum of 6o, the different H-F coupling constants were observed (Jϭ3 and 18 Hz) (Fig. 3) .
On the other hand, a PM3 calculation of 1g, mainly two conformations were calculated. One is an extended form, and the other is a folded form which has a 0.5 kcal/mol lower energy than extended form (Fig. 4) . In the 1 H-NMR spectrum of 1g, high magnetic field shifts of the phenyl protons were observed at d 6.30-6.40 and 6.65-6.75 (each 1H, m), which were due to the shielding effect of an aromatic ring. The PM3 calculation and 1 H-NMR spectra suggest that 1g take a folded conformation, and we presume that 1g cannot enter into the cytochrome P-450 pocket by steric hindrance and did not show any antifungal activities.
Compounds (ϩ)-1b, (ϩ)-1c, (ϩ)-1f and (ϩ)-1o showed antifungal activities, but those of (Ϫ)-form showed no significant activities. Especially, (ϩ)-1f showed activities superior to FLCZ and ITCZ against C. albicans, C. krusei, T. mentagrophytes, and T. rubrum, and activities equal to itraconazole against A. fumigatus and A. flavus.
Conclusion
We designed antifungal 1,2,4-triazoles (1) having a heteroaryl-gem-difluoromethylene moiety, which were synthesized using the coupling reaction of heteroaryl halides with an ethyl difluoroacetate-copper complex or the reaction of benzaldehydes with Reformatsky type reagents prepared from chlorodifluoro(heteroaryl)methanes and zinc, as the key reactions. The compounds 1 except for 1g showed strong antifungal activities and especially (ϩ)-1f showed activities equal or superior to ITCZ against yeasts and filamentous fungi.
Experimental
Melting points were determined on a Yanagimoto melting point apparatus without correction. IR spectra measured on a Nihon-bunko IR-810 spectrometer.
1 H-NMR spectra were recorded on a Hitachi FT-NMR R-3000 or Varian Gemini 2000 spectrometer using tetramethylsilane as a respective internal standard.
19 F-NMR spectra were recorded on a JOEL JNM-EX400 FT-NMR spectrometer in CDCl 3 with trifluoroacetic acid as an external standard. The following abbreviations are used: sϭsinglet, dϭdoublet, ddϭdou-ble doublet, dtϭdouble triplet, dddϭdouble double doublet, tϭtriplet, qϭquartet, mϭmultiplet, brϭbroad. MS or high-resolution mass spectra (HRMS) were obtained on a JEOL JMS-DX303 or JEOL JMS-AX500 mass spectrometer. Optical rotations were determined on a Horiba SEPA-300 polarimeter. HPLC were performed on a Hitachi L-6000 pump equipped with a Hitachi L-4000 detector. Preparative HPLC were carried out on a Yamazen 800E pump equipped with an UV-10V detector. Column chromatography was carried out on a silica gel (BW-80S Fuji-sirial). Resolution of (Ϯ)-1 was carried out by preparative HPLC on Chiralpak AS (2 cm I.D.ϫ25 cm) with pre-column Chiralpak AS (2 cm I.D.ϫ5 cm) (Daicell Chemical Industries, Ltd.) and optical yields were measured by HPLC using Chiralpack AS (4.6 mm I.D.ϫ250 mm) with pre-column Chiralpak AS (4.6 mm I.D.ϫ 50 mm) (Daicell Chemical Industries, Ltd.).
General Procedure for the Synthesis of Ethyl 2,2-Difluoro(heteroaryl)acetate (4) Ethyl bromodifluoroacetate (2 mmol) was added to a mixture of Cu powder (4 mmol) and DMSO (5 ml) at room temperature with stirring. After the mixture was stirred at the same temperature for 1 h, a heteroaryl halide (3) (1 mmol) was added to the solution at room temperature with stirring. The mixture was stirred at the same temperature for 15 h. After addition of aqueous NH 4 Cl, the mixture was extracted with CHCl 3 . The organic extract was washed with water and brine, dried over MgSO 4 , and evaporated under reduced pressure. The residue was chromatographed on a silica gel column using AcOEt-n-hexane [1 : 9 (v/v)] to give 4. : 3140. General Procedure for the Synthesis of 2m-p from 6 MnO 2 (2 g) was added to a solution of 6 (2.7 mmol) in CHCl 3 (10 ml) at room temperature with stirring for 15 h. The precipitate was filtered off, and the precipitate was washed with CHCl 3 . The filtrate was washed with water and brine, dried over MgSO 4 , and evaporated under reduced pressure. The residue was chromatographed on a silica gel column using AcOEt-n-hexane [1 : 9 (v/v)] to give 2. Methylbenzimidazol-2-yl)-2,2-difluoro-1-(2,4-difluorophenyl) 
2-(1-

1705.
General Procedure for the Synthesis of 2-Aryl-2-[difluoro(heteroaryl) methyl]oxirane (7) from 2 with Trimethylsulfoxonium Iodide DMSO (10 ml) in THF (5 ml) was added to NaH (60% in oil; 64 mg, 1.6 mmol) washed twice with n-hexane. To the mixture, was added TMSI (349 mg, 1.6 mmol). After stirring at room temperature for 1 h, the mixture was added to 2 (1.57 mmol) in THF (5 ml) at 0°C with stirring. The mixture was stirred at the same temperature for 1 h. After addition of aqueous NaHCO 3 , the mixture was extracted with AcOEt. The organic extract was washed with water and brine, dried over MgSO 4 , and evaporated under reduced pressure. The residue was chromatographed on a silica gel colum using n-hexaneAcOEt [9 : 1 (v/v)] to give 7.
General Procedure for the Synthesis of 7 from 2 with Diazomethane Diazomethane (0.29 M in Et 2 O; 10 ml) was added to a solution of 2e, n (0.5 mmol) in Et 2 O (10 ml) with stirring at 0°C. The mixture was stirred at room temperature for 12 h, and the solvent was evaporated under reduced pressure. The residue was chromatographed on a silica gel column using AcOEt-n-hexane [1 : 8 (v/v) of 1,1-Difluoro-1-heteroaryl-3-(1,2,4-triazol-1-yl)-2-propanol (1) 1,2 ,4-Triazole (70 mg, 1 mmol) and K 2 CO 3 (70 mg, 0.5 mmol) were added to a solution of 7 (0.93 mmol) in DMF (5 ml). The mixture was warmed at 65°C for 5 h. After addition of aqueous NaHCO 3 , the mixture was extracted with AcOEt. The organic extract was washed with water and brine, dried over MgSO 4 , and evaporated under reduced pressure. The residue was chromatographed on a silica gel column using CHCl 3 
